Closed mitral valvotomy was first reported by Cutler

Size: px
Start display at page:

Download "Closed mitral valvotomy was first reported by Cutler"

Transcription

1 Mitral Commissurotomy, a Technique Outdated? Long-Term Follow-up Over a Period of 35 Years Christian Detter, MD, Teddy Fischlein, MD, Christina Feldmeier, MD, Georg Nollert, MD, Hermann Reichenspurner, MD, PhD, and Bruno Reichart, MD Department of Cardiac Surgery, Klinikum Großhadern, Ludwig-Maximilians-University, Munich, Germany Background. The objective of this study was to evaluate long-term survival, valve-related complications as well as prognostic factors for early and late outcome after open and closed mitral commissurotomy covering a follow-up period of 35 years. Methods. From 1955 to 1977, 183 patients with mitral stenosis underwent mitral commissurotomy at our institution. Closed valvotomy was performed on 143 patients (group A) and open valvotomy on 40 patients (group B). Results. Survival rates after 10, 20, and 30 years were 89%, 67.8%, and 49.1% in group A and 91.7%, 66.7%, and 45.9% in group B (p not significant). The risk of late death increased significantly with an advanced preoperative New York Heart Association functional class, atrial fibrillation, higher age at operation, pre- or postoperative mitral regurgitation, and leaflet calcification. Forty-four patients in group A and 5 patients in group B required reoperation (p < 0.05). Independent predictors for reoperation in a multivariate analysis were a remaining postoperative mitral stenosis or regurgitation. A total of 68 patients showed valve-related complications. The linearized rate of valve-related morbidity and mortality was 2.1% per patient-years in group A versus 1.1% per patient-years in B (p < 0.01). Conclusions. Long-term survival for open and closed commissurotomy are excellent, showing no difference between the groups. However, both the incidence of reoperation as well as valve-related morbidity and mortality were significantly lower after open commissurotomy. In well-selected patients with pure mitral stenosis and no leaflet calcification, open commissurotomy still remains a valid surgical option. (Ann Thorac Surg 1999;68:2112 8) 1999 by The Society of Thoracic Surgeons Closed mitral valvotomy was first reported by Cutler and Levine [1] in 1923 and successfully performed by Harken and colleagues [2] in After the development of cardiopulmonary bypass, open mitral valvotomy was performed under direct vision for mitral stenosis in 1956 with improved hemodynamic results [3 8]. Today, in developed countries, closed mitral commissurotomy is still preferred to the open technique [9], with an ongoing controversy about the best approach [5 7, 10]. However, commissurotomy is a palliative surgical treatment that may require early reoperation. In addition, differences in hemodynamics and valve-related complications may affect long-term survival. Several studies showed that mitral commissurotomy resulted in better long-term survival rates and fewer valve-related complications if compared to valve replacement [11, 12]. We report our experience of both open and closed mitral commissurotomy covering a 35-year follow-up period evaluating long-term survival rates, valverelated complications, as well as prognostic factors for early and late outcome. Accepted for publication April 30, Address reprint requests to Dr Detter, Department of Cardiac Surgery, Klinikum Großhadern, Ludwig-Maximilians-University, D Munich, Germany; cdetter@hch.med.uni-muenchen.de. Patients and Methods Between August 1955 and July 1977, a total of 183 patients (135 female and 48 male patients) with valvular mitral stenosis underwent mitral commissurotomy at our institution. Closed valvotomy was performed on 143 patients (78.1%, group A) from 1955 to 1975 and open valvotomy on 40 patients (21.9%, group B) from 1960 to The average age of patients at the time of operation was years (range, 1 month to 64 years) in group A and years (range, 6 to 63 years) in group B. The majority of patients were in New York Heart Association (NYHA) functional class III or IV. Preoperative clinical characteristics of both groups were similar, as shown in Table 1. All patients underwent preoperative cardiac catheterization. One hundred eight patients in group A and 29 patients in group B had pure mitral valve stenosis. Additional mitral valve regurgitation was found in 35 patients of group A and in 11 patients of group B. Leaflet calcification was present in 43 (group A) and 12 (group B) patients, respectively. Patients with severe mitral incompetence or severe valve calcification did not undergo commissurotomy; those with concomitant aortic valvular disease or associated coronary artery bypass grafting were excluded from the study. Operative Techniques Closed valvotomy was performed through a left anterolateral thoracotomy. An incision was made in the left atrial appendage, followed by insertion of the right index 1999 by The Society of Thoracic Surgeons /99/$20.00 Published by Elsevier Science Inc PII S (99)

2 Ann Thorac Surg DETTER ET AL 1999;68: MITRAL COMMISSUROTOMY OUTDATED? 2113 Table 1. Preoperative Clinical Characteristics of Patients, Depending on Whether the Commissurotomy Was Performed by Closed or Open Technique Clinical Characteristics Closed (n 143) Open (n 40) Patients (n) Male/female 41/102 7/33 Age (y) (mean SD) NYHA class (mean SD) Mitral valve area (cm 2 ) (mean) Mitral valve regurgitation 36 (25.2%) 10 (25.0%) Leaflet calcification 43 (30.1%) 12 (30.0%) Atrial fibrillation 69 (48.3%) 16 (40.0%) Thromboembolic events 40 (28%) 8 (20%) Left atrial thrombus 9 (6.3%) 4 (10.0%) p Not significant. SD standard deviation. finger into the left atrium. The first 13 patients of this series underwent digital valvotomy; since 1960, however, predominantly a Tubbs or a Dubost transventricular dilator was used. A pursestring suture was placed at the apex of the left ventricle and the dilator was subsequently passed through the apical ventriculotomy to the mitral valve orifice. The dilator was then positioned across the mitral valve orifice by palpation and opened one to four times. Open valvotomy was performed through a median sternotomy or a right lateral approach. Operative management included cardiopulmonary bypass, a bubble oxygenator, moderate systemic hypothermia (28 C to 34 C) and induced ventricular fibrillation; cardioplegia was not given. For myocardial protection, cold saline solution was applied topically. The aorta was crossclamped and the left atrium was opened and examined for the presence of a thrombus. Fused mitral commissures were incised widely with attention being paid to avoid valve regurgitation. The open procedure was associated with other maneuvers including thrombectomy in 4 patients, decalcification in 3, splitting of fused chordae tendineae and papillary muscles in 5, and mitral annuloplasty using the Wooler technique in 3 patients. Mean duration of cardiopulmonary bypass was minutes, the aortic cross-clamp time was minutes. Mitral valve competence was confirmed by intraventricular injection of saline solution. After operation, the result was controlled by hemodynamic pressure measurements. Anticoagulation In the early postoperative period, heparin was used prophylactically to prevent thrombosis or emboli. In patients with sinus rhythm, anticoagulation was discontinued after hospital discharge. All patients with postoperative atrial fibrillation (35.9%) received long-term oral anticoagulation therapy with phenprocoumon. Follow-up The patients operative records were reviewed retrospectively. Survival and follow-up information was acquired by questionnaires and telephone interviews with patients, relatives, and family practitioners. A clinical examination including echocardiography and electrocardiogram was performed at our institution on identified not reoperated survivors. Valve function, valve morphology, transvalvular gradients, myocardial function, myocardial thickness, and the diameter of the atria and ventricles were determined. The functional status was assigned according to the NYHA. Mean follow-up time was years (median, 23.9 years; range, 0 to 36.2 years) in group A and years (median, 20.6 years; range, 0 to 35.8 years) in group B. Ten patients (7.0%) in group A and 1 patient (2.5%) in group B were lost to follow-up studies after hospital discharge. Follow-up was complete in 94% of the patients representing a total of 3,544 patient-years (group A, 2,839 patientyears; group B, 705 patient-years). The results of the operations performed are reported in accordance with the recommendations of the Ad Hoc Liaison Committee in Guidelines for Reporting Morbidity and Mortality After Cardiac Valvular Operations [13]. Statistical Analysis Continuous data were analyzed using the Mann- Whitney U test, categorical data using the 2 test. Values were expressed as mean standard deviation. Longterm survival and freedom from complications were calculated by the Kaplan-Meier method. These data were expressed as means standard error of the mean. Univariate analyses were carried out by means of logrank statistics, followed by a multivariate analysis using the Cox regression model. The variables included in the model were age, gender, operative year, preoperative NYHA class, preoperative cardiac medication, emergency operation, presence of left atrial thrombus, preoperative thromboembolism and atrial fibrillation, preoperative left ventricular enlargement, preoperative pulmonary vascular resistance, preoperative and postoperative mitral valve area and mitral regurgitation, leaflet calcification, operative technique (open versus closed), and all valve-related complications. Probability values less than 0.05 were considered significant. Statistical analysis was performed using the SPSS statistical software package 8.0 for Windows (SPSS Inc, Chicago, IL). Results Early Mortality Ten patients (7.0%) who underwent closed valvotomy and 3 patients (7.5%) who underwent open valvotomy died within the first 30 days after operation. In case of an elective surgical procedure three deaths (2.1%) occurred in group A and no deaths in group B. Three patients died in the operating room due to cardiac failure (group A)

3 2114 DETTER ET AL Ann Thorac Surg MITRAL COMMISSUROTOMY OUTDATED? 1999;68: Table 2. Causes of Late Death After Mitral Commissurotomy, Depending on Whether the Commissurotomy Was Performed by Closed or Open Technique Closed (n 133) Open (n 37) Causes of Late Death n % n % Valve-related death Cardiac death Cardiac failure Myocardial infarction Noncardiac death Pneumonia Renal failure Liver failure Metabolic Cancer Suicide Unknown Total Fig 1. Long-term survival (Kaplan-Meier) of patients after closed (crosses; group A) and open commissurotomy (squares; group B). Numbers below the curve indicate the numbers of patients at risk. and myocardial infarction (group B). All causes of perioperative death were not valve related. Among the clinical variables tested we identified the following significant risk factors for early mortality: advanced preoperative NYHA classification (p 0.002), emergency operation (p 0.001), atrial fibrillation (p 0.004), presence of preoperative cardiac medication (p 0.05), and left ventricular enlargement (p ). Patients with an additional mitral regurgitation showed a trend for a higher early mortality rate (p 0.07). Late Mortality Among the 170 operative survivors 60 patients (45.1%, 2.1% per patient-year) died after closed procedures and 17 (45.9%, 2.4% per patient-year) after open procedures (p not significant). The most frequent cause of late death was cardiac failure in 25 patients in group A and 10 patients in group B (Table 2). The Kaplan-Meier longterm survival curves for both groups are presented in Figure 1. Survival rates excluding early mortality after 10, 20, and 30 years were 89.0%, 67.8%, and 49.1% in group A and 91.7%, 66.7%, and 45.9% in group B (p not significant). Median survival of all patients was 29 years (group A) versus 23.9 years (group B). There were no statistically significant differences between the groups. Factors Influencing Late Survival With an advanced preoperative NYHA class (p 0.001; Fig 2A), preoperative atrial fibrillation (p ; Fig 2B), higher age at the time of operation (p ), additional pre- and postoperative mitral regurgitation (p 0.002; Fig 2C), and presence of leaflet calcification (p 0.05; Fig 2D), the risk of late death increased significantly in the univariate analysis. Elevated pulmonary vascular resistance did not have any effect on survival in this study but statistical power was low because data were not available in all patients. Valverelated complications during long-term follow-up, such as thromboembolic events, bacterial endocarditis, and anticoagulant-related hemorrhage, were not significantly related to late death. Reoperations improved long-term survival (p ). Multivariate analysis showed that advanced preoperative NYHA classes, higher age at the time of operation, and additional postoperative mitral regurgitation were significant predictors for late death. Valve-Related Complications VALVE-RELATED MORTALITY. There were 13 valve-related deaths in group A and 1 valve-related death in group B, representing a rate of 95.0%, 91.0%, and 85.0% in group A and 100%, 96.3%, and 96.3% in group B free of valverelated mortality at 10, 20, and 30 years (p not significant). Valve dysfunction due to recurrent mitral valve stenosis was the main cause of valve-related death. One patient died at reoperation of the mitral valve and thromboembolism was the cause of death in another patient. The linearized rate was 0.46% per patient-years in group A versus 0.14% per patient-years in group B (p not significant). THROMBOEMBOLISM. Postoperative thromboembolic events occurred in 9 patients in group A and in 2 patients in group B, corresponding to a linearized rate of 0.32% per patient-years in group A and 0.28% per patient-years in group B (p not significant). Two of these patients were anticoagulated at the time of the event; neither of the patients died. The freedom from thromboembolism at 10, 20, and 30 years was 95.2%, 93.1%, and 89.7% for group A patients versus 97.4%, 96.6%, and 92.7% for group B patients (p not significant). ANTICOAGULANT-RELATED HEMORRHAGE. Severe anticoagulant-related hemorrhage was observed in 9 patients in group A and in 2 patients in group B corresponding to a

4 Ann Thorac Surg DETTER ET AL 1999;68: MITRAL COMMISSUROTOMY OUTDATED? 2115 Fig 2. Survival curves (Kaplan-Meier) according to log-rank univariate analysis of significant variables. (A) The effect of preoperative New York Heart Association (NYHA) functional class (p 0.001); (B) preoperative atrial fibrillation (p ); (C) additional preoperative mitral regurgitation (p 0.002); and (D) presence of leaflet calcification (p 0.05) on survival rate. Numbers below the curve indicate the numbers of patients at risk. linearized rate of 0.32% per patient-years in group A and 0.28% in group B (p not significant). Two patients died due to cerebral hemorrhage. ENDOCARDITIS. Bacterial endocarditis occurred in 3 group A patients corresponding to a linearized rate of 0.11% per patient-years and none in group B. None of these patients died and one required reoperation. REOPERATION. Forty-four patients in group A and 5 patients in group B required reoperation of the mitral valve. The reoperation linearized rate was 1.55% per patient-years in A versus 0.71% per patient-years in B (p 0.05). The mean interval between the first and second procedure was years (median, 16.3; range, 1.0 to 31.0 years) with no significant difference between the two groups. The main indication for reoperation was restenosis of the mitral valve in 28 group A patients (19.6%) and in 5 group B patients (12.5%). Fifteen group A patients (10.5%) and none in group B required reoperation for severe mitral regurgitation (p 0.05). Of these, 5 patients showed a moderate mitral insufficiency immediately after the operation leading to early reoperation within the first 2 years in 2 patients (1.4%). One group A patient (0.7%) was reoperated due to mitral valve endocarditis. In 43 patients, a mitral valve replacement was performed. A repeated mitral commissurotomy was done in 3 patients, 2 patients needed balloon valvuloplasty and 1 patient required ring annuloplasty. Freedom from reoperation was 89.7% at 10 years, 73.5% at 20 years, and 49.5% at 30 years for group A patients and 93.9% at 10, 82.8% at 20 and 30 years for group B patients (Fig 3). One patient of group A (2.3%) and none of group B died during reoperation. Other cardiac procedures were necessary in 8 patients including aortic valve replacement in 2 patients, tricuspid valve operation in 3 patients, and coronary artery bypass grafting in 3 patients.

5 2116 DETTER ET AL Ann Thorac Surg MITRAL COMMISSUROTOMY OUTDATED? 1999;68: A standard electrocardiogram was used to provide additional information on cardiac rhythm. The electrocardiographic examination showed that 7 patients in group A and 4 patients in group B were in normal sinus rhythm. Atrial fibrillation was apparent in 21 patients (70%) of group A and in 10 patients (66.6%) of group B. A pacemaker was implanted in 2 patients of group A and in 1 patient of group B. Fig 3. Freedom from reoperation (Kaplan-Meier) of patients after closed (crosses; group A) and open commissurotomy (squares; group B). Numbers below the curve indicate the numbers of patients at risk. Multivariate analysis of risk factors identified as independent predictors of reoperation a remaining postoperative mitral stenosis (p 0.05) and mitral regurgitation (p 0.05). In the univariate model, leaflet calcification showed a trend for a higher reoperation rate (p 0.05). Higher NYHA class (III or IV) showed no statistically relevant effect on subsequent operation (p not significant). VALVE-RELATED MORBIDITY AND MORTALITY. This combination includes all valve-related deaths and all nonfatal valverelated morbid events. In total, 68 patients developed a valve-related complication. The linearized rate was 2.1% per patient-years in group A versus 1.1% per patientyears in group B (p 0.01). Freedom from valve-related morbidity and mortality was 83.2% at 10 years, 63.7% at 20 years, and 38.4% at 30 years in group A and 87.9% at 10, and 73.5% at 20 and 30 years in group B. Clinical Follow-up in Surviving Patients At the time of follow-up 82 patients were still alive. Of these, 30 patients who underwent closed commissurotomy and 15 patients who underwent open commissurotomy did not require reoperation. The follow-up period for all patients still alive and not requiring reoperation was between 17.8 and 34.5 years with a mean of years. Nineteen patients (63.3%) who underwent closed commissurotomy and 10 patients (66.7%) who underwent open commissurotomy are currently in NYHA functional class I or II; 11 patients in group A and 5 patients in group B were in class III and none in class IV. There are no statistically relevant differences between the two groups. In group A, 55.6% and in group B, 73.7% of the patients are retired; 41.2% and 26.3%, respectively, are working, whereas only 3.2% of patients in group A are unable to work. Echocardiographic Results Echocardiographic evaluations were performed in 44 of 45 surviving patients with no subsequent reoperation. The mean pressure gradients ranged between 3 and 18 mm Hg, with a mean of 5.5 mm Hg in group A and 5.4 mm Hg in group B. A significant mitral valve stenosis (mitral valve area, 1.5 cm 2 ) was seen in 13.3% of group A and 14.3% of group B patients. Severe valve incompetence (mitral valve insufficiency grade III) was present in 6.7% in group A and 7.1% in group B. Left ventricular myocardial function was measured as a function of fractional shortening and proved to be normal in 60% group A patients and 64.3% group B patients. All echocardiographic results are summarized in Table 3. There were no statistically relevant differences between the two groups. Comment Although closed mitral commissurotomy showed good results [14 16], this technique has been totally replaced by the open procedure [6, 11, 17 20]. The latter allows for direct inspection of the valve morphology, debridement of calcium depositions, division of subvalvular fusions, and the removal of left atrial thrombi [5, 7, 19]. At our institution we performed closed mitral commissurotomy since 1955, whereas the open approach for operative treatment of mitral stenosis was used between 1960 and In this study, early mortality was similar in both the closed and open technique and slightly higher when compared to that reported by other investigators [5, 6, 14, 21]. This is probably related to the first experiences made in cardiac surgery and to the fact that in the early 1950s and 1960s postoperative intensive care medicine was still at a developing stage. However, the open technique included short periods of cardiopulmonary bypass and myocardial ischemia not protected by cardioplegia making it a riskier procedure in the early days of cardiac surgery. The present study showed excellent long-term results in both open and closed commissurotomy. The survival rates of our patients are within the range of other studies [10, 15, 19, 21]. Most studies showed no difference in survival rates between the closed and open technique [10, 16, 21]. Scalia and colleagues [21] showed identical survival rates using both techniques. Hickey and associates [10] were also able to demonstrate that the operative technique was not a risk factor for long-term survival. On the contrary, Nakano and colleagues [20] concluded that

6 Ann Thorac Surg DETTER ET AL 1999;68: MITRAL COMMISSUROTOMY OUTDATED? 2117 Table 3. Echocardiographic Results and Doppler Measurements (n 44) in Surviving Patients With No Subsequent Reoperation, Depending on Whether the Commissurotomy Was Performed by Closed (n 30) or Open Technique (n 14) Variable Closed Open Mean pressure gradient (mm Hg) Range Mean Mitral valve area (cm 2 ) Range Mean MVA 1.5 cm 2 4 (13.3%) 2 (14.3%) Mitral insufficiency None %) 4 (28.6%) Insufficiency grade I 14 (46.7%) 7 (50.0%) Insufficiency grade II 5 (16.7%) 2 (14.3%) Insufficiency grade III 2 (6.7%) 1 (7.1%) Left ventricular function (%) Mean FS 30% 18 (60.0%) 9 (64.3%) FS 15% 30% 11 (36.%) 5 (35.7%) FS 15% 1 (3.3%) 0 Left ventricular morphology Normal 22 (3.3%) 11 (7.6%) Hypertrophic (IVS d,pw d 5 (16.7%) 1 (7.1%) 12 mm) Dilated (LV EDD 56 mm) 3 (10.0%) 2 (14.3%) Left atrium Mean Normal 7(23.3%) 2 (14.3%) Dilated (LA d 40 mm) 23 (76.7%) 12 (85.7%) p Not significant. FS fractional shortening; IVS d diameter of interventricular septum; LA d diameter of left atrium; LV EDD left ventricular end-diastolic diameter; MVA mitral valve area; PW d diameter of posterior wall. open commissurotomy was the procedure of choice, as survival rates and freedom from reoperation were preferable. The present study did not show any significant differences between the two groups in terms of long-term survival. Factors that might contribute to the outcome of mitral commissurotomy and affect long-term survival have been evaluated in the present study. The risk of early and late death increased significantly with advanced preoperative NYHA class, preoperative atrial fibrillation, and higher age at the time of operation. Eguaras and associates [18] also demonstrated better results for early commissurotomy in young patients with sinus rhythm who are free of symptoms. Our group observed a significant impairment of long-term survival by additional pre- or postoperative mitral regurgitation and presence of leaflet calcification. Thus, this procedure is only indicated in patients presenting with no or mild mitral insufficiency and a flexible mitral valve free of calcification [18]. In accordance with other researchers we believe that mitral commissurotomy should be performed as early as possible to prevent progressive valve changes, which make reconstruction impossible [7, 18, 22]. Such early surgical intervention could possibly prevent serious secondary changes such as left atrial hypertrophy, atrial fibrillation, pulmonary hypertension, tricuspid insufficiency, and the risk of thromboembolism [11]. Thus, early operation and the proper selection of patients should be the major goal when performing a commissurotomy. Reoperations of the mitral valve were more frequent in closed valvotomy than in the open technique, as demonstrated previously [8, 21, 22]. In part, this is attributable to postoperative mitral regurgitation, which is more likely to occur with the blind technique. In fact, 5 of 15 patients in group A who required reoperation for severe mitral regurgitation showed moderate mitral insufficiency immediately after operation. In contrast, none of group B patients needed reoperation for this reason. Here, the open technique might be favorable as mitral annuloplasty could be performed immediately if necessary. However, the main indication for reoperation was a restenosis of the mitral valve. Of these patients, 12 already had leaflet calcification and severe fusion of the subvalvular apparatus when first operated. Herrera and colleagues [19] stated that the incidence of restenosis is intimately connected with the fusion of the subvalvular apparatus and that a complete repair is a crucial factor to produce a satisfactory long-term result. Hickey and associates [10] showed that the severity of stenosis, the degree of leaflet calcification, and the degree of postcommissurotomy mitral incompetence were incremental risk factors for subsequent mitral valve procedure. In fact, risk analysis identified as significant risk factors for reoperation a remaining postoperative mitral stenosis, mitral regurgitation, and leaflet calcification. Although commissurotomy of the valve is a more palliative surgical treatment, the median interval between the initial commissurotomy and reoperation was 16.3 years, without significant differences between the groups. This is probably the best proof of the effectiveness of mitral commissurotomy [10]. However, there was only one early death (2.1%) in patients who underwent reoperation. Because early mortality is low and long-term survival significantly improves after reoperation as shown in the multivariate analysis, second surgical interventions should be performed before serious secondary changes arise. If reoperation is necessary, valve replacement is the preferred method because of the severe pathologic changes of the valve [20, 21, 23]. The low incidence of valve-related complications with a thromboembolism rate of 0.32% per patient-years in group A and 0.28% per patient-years in group B is comparable with other publications [4, 6, 17]; it is furthermore significantly lower when compared to that of mitral valve replacements in the same period [11]. Over the years, anticoagulation therapy may be required because of atrial fibrillation, a history of thromboembolism, or an enlarged left atrium. The valve-related morbidity and mortality proved to be low, supporting the view that a commissurotomy should

7 2118 DETTER ET AL Ann Thorac Surg MITRAL COMMISSUROTOMY OUTDATED? 1999;68: be performed whenever indicated. In this study, valverelated morbidity and mortality was significantly lower in open commissurotomy when compared to the closed technique. This is mainly attributable to fewer reoperations and a lower rate of valve-related deaths in the open procedure. Farhat and colleagues [24] were able to show that after open commissurotomy hemodynamics improved to a greater extent than with closed commissurotomy and that open valvotomy is more effective in relieving the obstruction even when performed on selected patients with no preoperative mitral regurgitation. The fact that almost two-thirds of the surviving patients are in NYHA class I or II and only 3.2% were unable to work demonstrates that for a follow-up period of 35 years after commissurotomy patients enjoy a good quality of life. Nearly a quarter of the patients involved are still in sinus rhythm. Also in the majority of patients not requiring reoperation, the echocardiographic evaluations showed good results. Significant mitral valve stenosis occurred in 13.6% and severe valve incompetence in only 6.8%. Most patients had a good left ventricular function with normal myocardial diameters, which highlights the excellent hemodynamic of the native valve. In conclusion, long-term results for open as well as for closed commissurotomy are excellent. Although commissurotomy represents a more palliative surgical treatment and reoperation may occur, patients who underwent this procedure do benefit both in terms of low valve-related complications and a good quality of life. However, in terms of early and late survival this study did not show any significant differences between the open and closed technique. Nevertheless, the incidence of reoperation as well as of valve-related morbidity and mortality was significantly lower after open commissurotomy. The open technique produced no early failures due to postoperative mitral regurgitation. In addition, the open technique allows the surgeon to remove atrial thrombi, to repair the subvalvular apparatus, to carry out debridement of calcium deposits, and to perform an annuloplasty. Thus, open commissurotomy is a safe surgical intervention with an excellent long-term survival rate and a low incidence of valve-related complications. In well-selected patients with pure mitral stenosis and no leaflet calcification, open commissurotomy still remains a valid surgical option. References 1. Cutler EC, Lewine SA. Cardiotomy and valvulotomy for mitral stenosis. Experimental observations and clinical notes concerning an operated cases with recovery. Boston Med Surg J 1923;188: Harken DE, Ellis LB, Ware PF, Norman LR. The surgical treatment of mitral stenosis: I. Valvuloplasty. N Engl J Med 1948;239: Smith WM, Neutze JM, Barratt-Boyes BG, Lowe JB. Open mitral valvotomy. J Thorac Cardiovasc Surg 1981;82: Housman LB, Bonchek L, Lambert L, Grunkemeier G, Starr A. Prognosis of patients after open mitral commissurotomy. Actuarial analysis of late results in 100 patients. J Thorac Cardiovasc Surg 1977;73: Finnegan JO, Gray DC, MacVaugh H III, Joyner CR, Johnson J. The open approach to mitral commissurotomy. J Thorac Cardiovasc Surg 1974;67: Halseth WL, Elliott DP, Walker EL, Smith EA. Open mitral commissurotomy. J Thorac Cardiovasc Surg 1980;80: Spencer FC. A plea for early, open mitral commissurotomy. Am Heart J 1978;95: Vega JL, Fleitas M, Martinez R, et al. Open mitral commissurotomy. Ann Thorac Surg 1981;31: Cheng T. Closed mitral commissurotomy is not obsolete in developed countries. Am J Cardiol 1989;63: Hickey MSJ, Blackstone EH, Kirklin JW, Dean LS. Outcome probabilities and life history after surgical mitral commissurotomy: implications for balloon commissurotomy. J Am Coll Cardiol 1991;17: Laschinger JC, Cunningham JN, Baumann FG, et al. Early open radical commissurotomy: surgical treatment of choice for mitral stenosis. Ann Thorac Surg 1982;34: Eguaras MG, Luque I, Montero A, et al. A comparison of repair and replacement for mitral stenosis with partially calcified valve. J Thorac Cardiovasc Surg 1990;100: Edmunds LH Jr, Clark RE, et al. Guidelines for reporting morbidity and mortality after cardiac valvular operations. Ann Thorac Surg 1996;62: Rihal CS, Schaff HV, Frye RL, Bailey KR, Hammes LN, Holmes DR. Long-term follow-up of patients undergoing closed transventricular mitral commissurotomy: a useful surrogate for percutaneous balloon mitral valvuloplasty? J Am Coll Cardiol 1992;20: John S, Bashi VV, Jairaj PS, et al. Closed mitral valvotomy: early results and long-term follow-up of 3724 consecutive patients. Circulation 1983;68: Molajo AO, Bennett DH, Bray CL, et al. Actuarial analysis of late results after closed mitral valvotomy. Ann Thorac Surg 1988;45: Montoya A, Mulet J, Pifarré R, Moran JM, Sullivan HJ. The advantages of open mitral commissurotomy for mitral stenosis. Chest 1979;75: Eguaras MG, Jimenez MA, Calleja F, et al. Early open mitral commissurotomy: long-term results. J Thorac Cardiovasc Surg 1993;106: Herrera JM, Vega JL, Bernal JM, Rabasa JM, Revuelta JM. Open mitral commissurotomy: fourteen- to eighteen-year follow-up clinical study. Ann Thorac Surg 1993;55: Nakano S, Kawashima Y, Hirose H, et al. Reconsiderations of indications for open mitral commissurotomy based on pathologic features of the stenosed mitral valve. J Thorac Cardiovasc Surg 1987;94: Scalia D, Rizzoli G, Campanile F, et al. Long-term results of mitral commissurotomy. J Thorac Cardiovasc Surg 1993;105: Eguaras MG, Luque I, Montero A, et al. Conservative operation for mitral stenosis. J Thorac Cardiovasc Surg 1988;95: Isomura T, Hisatomi K, Satoh T, Hirano A, Kosuga K, Ohishi K. Clinical study of 47 patients with reoperation after open mitral commissurotomy. J Cardiovasc Surg 1993;34: Farhat MB, Boussadia H, Gandjbakhch I, et al. Closed vesus open mitral commissurotomy in pure noncalcific mitral stenosis: hemodynamic studies before and after operation. J Thorac Cardiovasc Surg 1990;99:

Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease

Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease TIRONE E. DAVID, MD ; SEMIN THORAC CARDIOVASC SURG 19:116-120c 2007 ELSEVIER INC. PRESENTED BY INTERN 許士盟 Mitral valve

More information

16 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 6900

16 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 6900 CLINICAL COMMUNIQUé 6 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 69 The Carpentier-Edwards PERIMOUNT Mitral Pericardial Valve, Model 69, was introduced into clinical

More information

M operations, with closed mitral valvotomy first reported

M operations, with closed mitral valvotomy first reported Comparison of Balloon Valvuloplasty With Operative Treatment for Mitral Stenosis Jeffrey M. Cohen, MHS, Donald D. Glower, MD, J. Kevin Harrison, MD, Thomas M. Bashore, MD, William D. White, MPH, L. Richard

More information

Long-term results (22 years) of the Ross Operation a single institutional experience

Long-term results (22 years) of the Ross Operation a single institutional experience Long-term results (22 years) of the Ross Operation a single institutional experience Authors: Costa FDA, Schnorr GM, Veloso M,Calixto A, Colatusso D, Balbi EM, Torres R, Ferreira ADA, Colatusso C Department

More information

Does Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement?

Does Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement? Original Article Does Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement? Hiroaki Sakamoto, MD, PhD, and Yasunori Watanabe, MD, PhD Background: Recently, some articles

More information

Idiopathic Hypertrophic Subaortic Stenosis and Mitral Stenosis

Idiopathic Hypertrophic Subaortic Stenosis and Mitral Stenosis CASE REPORTS Idiopathic Hypertrophic Subaortic Stenosis and Mitral Stenosis Martin J. Nathan, M.D., Roman W. DeSanctis, M.D., Mortimer J. Buckley, M.D., Charles A. Sanders, M.D., and W. Gerald Austen,

More information

Ischemic mitral valve reconstruction and replacement: Comparison of long-term survival and complications

Ischemic mitral valve reconstruction and replacement: Comparison of long-term survival and complications Surgery for Acquired Cardiovascular Disease Ischemic mitral valve reconstruction and replacement: Comparison of long-term survival and complications Eugene A. Grossi, MD Judith D. Goldberg, ScD Angelo

More information

CLINICAL COMMUNIQUE 16 YEAR RESULTS

CLINICAL COMMUNIQUE 16 YEAR RESULTS CLINICAL COMMUNIQUE 6 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 6900 Introduction The Carpentier-Edwards PERIMOUNT Mitral Pericardial Valve, Model 6900, was introduced

More information

The Edge-to-Edge Technique f For Barlow's Disease

The Edge-to-Edge Technique f For Barlow's Disease The Edge-to-Edge Technique f For Barlow's Disease Ottavio Alfieri, Michele De Bonis, Elisabetta Lapenna, Francesco Maisano, Lucia Torracca, Giovanni La Canna. Department of Cardiac Surgery, San Raffaele

More information

Repair or Replacement

Repair or Replacement Surgical intervention post MitraClip Device: Repair or Replacement Saudi Heart Association, February 21-24 Rüdiger Lange, MD, PhD Nicolo Piazza, MD, FRCPC, FESC German Heart Center, Munich, Germany Division

More information

Clinical material and methods. Copyright by ICR Publishers 2003

Clinical material and methods. Copyright by ICR Publishers 2003 Fourteen Years Experience with the CarboMedics Valve in Young Adults with Aortic Valve Disease Jan Aagaard 1, Jens Tingleff 2, Per V. Andersen 1, Christel N. Hansen 2 1 Department of Cardio-Thoracic and

More information

Presenter Disclosure. Patrick O. Myers, M.D. No Relationships to Disclose

Presenter Disclosure. Patrick O. Myers, M.D. No Relationships to Disclose Presenter Disclosure Patrick O. Myers, M.D. No Relationships to Disclose Aortic Valve Repair by Cusp Extension for Rheumatic Aortic Insufficiency in Children Long term Results and Impact of Extension Material

More information

Mechanical Bleeding Complications During Heart Surgery

Mechanical Bleeding Complications During Heart Surgery Mechanical Bleeding Complications During Heart Surgery Arthur C. Beall, Jr., M.D., Kenneth L. Mattox, M.D., Mary Martin, R.N., C.C.P., Bonnie Cromack, C.C.P., and Gary Cornelius, C.C.P. * Potential for

More information

The production of murmurs is due to 3 main factors:

The production of murmurs is due to 3 main factors: Heart murmurs The production of murmurs is due to 3 main factors: high blood flow rate through normal or abnormal orifices forward flow through a narrowed or irregular orifice into a dilated vessel or

More information

Basic principles of Rheumatic mitral valve Repair

Basic principles of Rheumatic mitral valve Repair Basic principles of Rheumatic mitral valve Repair Prof. Gebrine El Khoury, MD DEPARTMENT OF CARDIOVASCULAR AND THORACIC SURGERY ST. LUC HOSPITAL - BRUSSELS, BELGIUM 1 Rheumatic MV disease MV repair confers

More information

Effect of Valve Suture Technique on Incidence of Paraprosthetic Regurgitation and 10-Year Survival

Effect of Valve Suture Technique on Incidence of Paraprosthetic Regurgitation and 10-Year Survival Effect of Valve Suture Technique on Incidence of Paraprosthetic Regurgitation and 10-Year Survival Sukumaran K. Nair, FRCS (C Th), Gauraang Bhatnagar, MBBS, Oswaldo Valencia, MD, and Venkatachalam Chandrasekaran,

More information

A Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision

A Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision A Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision Prof. Pino Fundarò, MD Niguarda Hospital Milan, Italy Introduction

More information

Which Type of Secondary Tricuspid Regurgitation Accompanying Mitral Valve Disease Should Be Surgically Treated?

Which Type of Secondary Tricuspid Regurgitation Accompanying Mitral Valve Disease Should Be Surgically Treated? Ann Thorac Cardiovasc Surg 2013; 19: 428 434 Online January 31, 2013 doi: 10.5761/atcs.oa.12.01929 Original Article Which Type of Secondary Tricuspid Regurgitation Accompanying Mitral Valve Disease Should

More information

Bicuspid aortic root spared during ascending aorta surgery: an update of long-term results

Bicuspid aortic root spared during ascending aorta surgery: an update of long-term results Short Communication Bicuspid aortic root spared during ascending aorta surgery: an update of long-term results Marco Russo, Guglielmo Saitto, Paolo Nardi, Fabio Bertoldo, Carlo Bassano, Antonio Scafuri,

More information

The production of murmurs is due to 3 main factors:

The production of murmurs is due to 3 main factors: Heart murmurs The production of murmurs is due to 3 main factors: high blood flow rate through normal or abnormal orifices forward flow through a narrowed or irregular orifice into a dilated vessel or

More information

Results of Mitral Valve Replacement, with Special Reference to the Functional Tricuspid Insufficiency

Results of Mitral Valve Replacement, with Special Reference to the Functional Tricuspid Insufficiency Results of Mitral Valve Replacement, with Special Reference to the Functional Tricuspid Insufficiency Ken-ichi ASANO, M.D., Masahiko WASHIO, M.D., and Shoji EGUCHI, M.D. SUMMARY (1) Surgical results of

More information

Durability and Outcome of Aortic Valve Replacement With Mitral Valve Repair Versus Double Valve Replacement

Durability and Outcome of Aortic Valve Replacement With Mitral Valve Repair Versus Double Valve Replacement Durability and Outcome of Aortic Valve Replacement With Mitral Valve Repair Versus Double Valve Replacement Masaki Hamamoto, MD, Ko Bando, MD, Junjiro Kobayashi, MD, Toshihiko Satoh, MD, MPH, Yoshikado

More information

Bogdan A. Popescu. University of Medicine and Pharmacy Bucharest, Romania. EAE Course, Bucharest, April 2010

Bogdan A. Popescu. University of Medicine and Pharmacy Bucharest, Romania. EAE Course, Bucharest, April 2010 Bogdan A. Popescu University of Medicine and Pharmacy Bucharest, Romania EAE Course, Bucharest, April 2010 This is how it started Mitral stenosis at a glance 2D echo narrow diastolic opening of MV leaflets

More information

Mitral Valve Disease. Chapter 29

Mitral Valve Disease. Chapter 29 Chapter 29 Mitral Valve Disease Thomas R. Griggs Mitral valve leaflets consist of thin, pliable, fibrous material. The two leaflets anterior and posterior open by unfolding against the ventricular wall

More information

Mitral Valve Repair Versus Replacement in Simultaneous Mitral and Aortic Valve Surgery for Rheumatic Disease

Mitral Valve Repair Versus Replacement in Simultaneous Mitral and Aortic Valve Surgery for Rheumatic Disease Mitral Valve Repair Versus Replacement in Simultaneous Mitral and Aortic Valve Surgery for Rheumatic Disease Kenji Kuwaki, MD, PhD, Nobuyoshi Kawaharada, MD, PhD, Kiyofumi Morishita, MD, PhD, Tetsuya Koyanagi,

More information

Ann Thorac Cardiovasc Surg 2015; 21: Online April 18, 2014 doi: /atcs.oa Original Article

Ann Thorac Cardiovasc Surg 2015; 21: Online April 18, 2014 doi: /atcs.oa Original Article Ann Thorac Cardiovasc Surg 2015; 21: 53 58 Online April 18, 2014 doi: 10.5761/atcs.oa.13-00364 Original Article The Impact of Preoperative and Postoperative Pulmonary Hypertension on Long-Term Surgical

More information

The Advantages of Open Mitral Commissurotomy for Mitral Stenosis*

The Advantages of Open Mitral Commissurotomy for Mitral Stenosis* The Advantages of Open Mitral Commissurotomy for Mitral Stenosis* Alvaro Montoya, M.D.; Jaime Mulet, M.D.;t Roque Pifarre, M.D., F.C.C.P.;; John M. Moran, M.D., F.C.C.P.; and Henry ]. Sullivan, M.D. Mitral

More information

Clinical material and methods. Fukui Cardiovascular Center, Fukui, Japan

Clinical material and methods. Fukui Cardiovascular Center, Fukui, Japan Mitral Valve Regurgitation after Atrial Septal Defect Repair in Adults Shohei Yoshida, Satoshi Numata, Yasushi Tsutsumi, Osamu Monta, Sachiko Yamazaki, Hiroyuki Seo, Takaaki Samura, Hirokazu Ohashi Fukui

More information

Carpentier-Edwards Pericardial Valve in the Aortic Position: 25-Years Experience

Carpentier-Edwards Pericardial Valve in the Aortic Position: 25-Years Experience SURGERY: The Annals of Thoracic Surgery CME Program is located online at http://www.annalsthoracicsurgery.org/cme/ home. To take the CME activity related to this article, you must have either an STS member

More information

ORIGINAL PAPER. The long-term results and changing patterns of biological valves at the mitral position in contemporary practice in Japan

ORIGINAL PAPER. The long-term results and changing patterns of biological valves at the mitral position in contemporary practice in Japan Nagoya J. Med. Sci. 78. 369 ~ 376, 2016 doi:10.18999/nagjms.78.4.369 ORIGINAL PAPER The long-term results and changing patterns of biological valves at the mitral position in contemporary practice in Japan

More information

The role of percutaneous mitral balloon valvuloplasty

The role of percutaneous mitral balloon valvuloplasty Which Patients Benefit From Percutaneous Mitral Balloon Valvuloplasty? Prevalvuloplasty and Postvalvuloplasty Variables That Predict Long-Term Outcome Igor F. Palacios, MD; Pedro L. Sanchez, MD; Lari C.

More information

Valvular Heart Disease Mitral Stenosis

Valvular Heart Disease Mitral Stenosis Valvular Heart Disease Mitral Stenosis A 75 year old woman with loud first heart sound and mid-diastolic murmur Chronic dyspnea Class 2/4 Fatigue Recent orthopnea/pnd Nocturnal palpitation Pedal edema

More information

Influence of Atrial Fibrillation on Outcome Following Mitral Valve Repair

Influence of Atrial Fibrillation on Outcome Following Mitral Valve Repair Influence of Atrial Fibrillation on Outcome Following Mitral Valve Repair Eric Lim, MBChB, MRCS; Clifford W. Barlow, DPhil, FRCS; A. Reza Hosseinpour, FRCS; Christopher Wisbey, BA; Kate Wilson, RN, BSc;

More information

13/06/2018. Rheumatic Mitral Stenosis: What does the ESC Guideline say? Mitral Stenosis: Echo Assessment. Mitral Stenosis ESC Guidance 2017

13/06/2018. Rheumatic Mitral Stenosis: What does the ESC Guideline say? Mitral Stenosis: Echo Assessment. Mitral Stenosis ESC Guidance 2017 Rheumatic Mitral Stenosis: What does the ESC Guideline say? Mitral Stenosis: Echo Assessment Dave Northridge Edinburgh Heart Centre Rheumatic mitral stenosis Prosthetic mitral dysfunction Calcific/degenerative

More information

Surgical repair techniques for IMR: future percutaneous options?

Surgical repair techniques for IMR: future percutaneous options? Surgical repair techniques for IMR: can this teach us about future percutaneous options? Genk - Belgium Prof. Dr. R. Dion KULeu Disclosure slide Robert A. Dion I disclose the following financial relationships:

More information

A Fifteen-Year Follow-up Study of

A Fifteen-Year Follow-up Study of A Fifteen-Year Follow-up Study of Closed Mitral Valvuloplasty Emanuel K. Nathaniels, M.D., Ashby C. Moncure, M.D., and J. Gordon Scannell, M.D. I n 1960 a five-year follow-up study of 100 consecutive patients

More information

TSDA Boot Camp September 13-16, Introduction to Aortic Valve Surgery. George L. Hicks, Jr., MD

TSDA Boot Camp September 13-16, Introduction to Aortic Valve Surgery. George L. Hicks, Jr., MD TSDA Boot Camp September 13-16, 2018 Introduction to Aortic Valve Surgery George L. Hicks, Jr., MD Aortic Valve Pathology and Treatment Valvular Aortic Stenosis in Adults Average Course (Post mortem data)

More information

Mitral Gradients and Frequency of Recurrence of Mitral Regurgitation After Ring Annuloplasty for Ischemic Mitral Regurgitation

Mitral Gradients and Frequency of Recurrence of Mitral Regurgitation After Ring Annuloplasty for Ischemic Mitral Regurgitation Mitral Gradients and Frequency of Recurrence of Mitral Regurgitation After Ring Annuloplasty for Ischemic Mitral Regurgitation Matthew L. Williams, MD, Mani A. Daneshmand, MD, James G. Jollis, MD, John

More information

SUBJECTS AND METHODS

SUBJECTS AND METHODS Acquired Mitral Stenosis in Children under Fifteen Boonchob PONGPANICH, M.D. and Sahas LIAMSUWAN, M.D. SUMMARY The clinical and hemodynamic studies of acquired MS in 30 children under the age of 15 are

More information

Case Report Successful Treatment of Double-Orifice Mitral Stenosis with Percutaneous Balloon Mitral Commissurotomy

Case Report Successful Treatment of Double-Orifice Mitral Stenosis with Percutaneous Balloon Mitral Commissurotomy Case Reports in Cardiology Volume 2012, Article ID 315175, 4 pages doi:10.1155/2012/315175 Case Report Successful Treatment of Double-Orifice Mitral Stenosis with Percutaneous Balloon Mitral Commissurotomy

More information

Mitral valve repair is the procedure of choice in SURGERY FOR ACQUIRED CARDIOVASCULAR DISEASE

Mitral valve repair is the procedure of choice in SURGERY FOR ACQUIRED CARDIOVASCULAR DISEASE SURGERY FOR ACQUIRED CARDIOVASCULAR DISEASE MITRAL VALVE REPAIR AND REPLACEMENT FOR RHEUMATIC DISEASE Terrence M. Yau, MD, MSc Yasser A. Farag El-Ghoneimi, MD Susan Armstrong, MSc Joan Ivanov, MSc Tirone

More information

The operative mortality rate after redo valvular operations

The operative mortality rate after redo valvular operations Clinical Outcomes of Redo Valvular Operations: A 20-Year Experience Naoto Fukunaga, MD, Yukikatsu Okada, MD, Yasunobu Konishi, MD, Takashi Murashita, MD, Mitsuru Yuzaki, MD, Yu Shomura, MD, Hiroshi Fujiwara,

More information

The use of mitral valve (MV) repair to correct mitral

The use of mitral valve (MV) repair to correct mitral Outcomes and Long-Term Survival for Patients Undergoing Repair Versus Effect of Age and Concomitant Coronary Artery Bypass Grafting Vinod H. Thourani, MD; William S. Weintraub, MD; Robert A. Guyton, MD;

More information

MITRAL STENOSIS. Joanne Cusack

MITRAL STENOSIS. Joanne Cusack MITRAL STENOSIS Joanne Cusack BSE Breakdown Recognition of rheumatic mitral stenosis Qualitative description of valve and sub-valve calcification and fibrosis Measurement of orifice area by planimetry

More information

Experience with 500 Stentless Aortic Valve Replacements

Experience with 500 Stentless Aortic Valve Replacements Experience with 500 Stentless Aortic Valve Replacements Dimitrios C. Iliopoulos, MD Cardiac Surgeon Ass. Professor of Surgery University of Athens, School of Medicine I declare no conflict of interest

More information

Quality Outcomes Mitral Valve Repair

Quality Outcomes Mitral Valve Repair Quality Outcomes Mitral Valve Repair Moving Beyond Reoperation Rakesh M. Suri, D.Phil. Professor of Surgery 2015 MFMER 3431548-1 Disclosure Mayo Clinic Division of Cardiovascular Surgery Research funding

More information

Ischemic Mitral Regurgitation

Ischemic Mitral Regurgitation Ischemic Mitral Regurgitation 1 / 6 2 / 6 3 / 6 Ischemic Mitral Regurgitation Background Myocardial infarction (MI) can directly cause (IMR), which has been touted as an indicator of poor prognosis in

More information

For rheumatic mitral stenosis, percutaneous balloon

For rheumatic mitral stenosis, percutaneous balloon CARDIOVASCULAR Consequence of Atrial Fibrillation and the Risk of Embolism After Percutaneous Mitral Commissurotomy: The Necessity of the Maze Procedure Hiroyuki Nakajima, MD, Junjiro Kobayashi, MD, Ko

More information

Repair of Congenital Mitral Valve Insufficiency

Repair of Congenital Mitral Valve Insufficiency Repair of Congenital Mitral Valve Insufficiency Roland Hetzer, MD, PhD, and Eva Maria Delmo Walter, MS, MD, PhD Principles of Mitral Valve Repair We believe that mitral valve repair for congenital mitral

More information

Balloon Dilatation of the Cardiac Valves

Balloon Dilatation of the Cardiac Valves 2 3 Balloon Dilatation of the Cardiac Valves Igor F. Palacios and Pedro L. Sánchez Percutaneous Pulmonic Valvuloplasty.............. 557 Percutaneous Mitral Balloon Valvotomy for Patients with Rheumatic

More information

Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014

Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications for cardiac catheterization Before a decision to perform an invasive procedure such

More information

Valve Repair for Mitral Regurgitation Caused by Isolated Prolapse of the Posterior Leaflet

Valve Repair for Mitral Regurgitation Caused by Isolated Prolapse of the Posterior Leaflet Valve Repair for Mitral Regurgitation Caused by Isolated Prolapse of the Posterior Leaflet Patrick Perier, MD, J/2rgen Stumpf, MD, Christian GStz, MD, Fitsoum Lakew, MD, Andr6 Schneider, MD, Bernd Clausnizer,

More information

The Tricuspid Valve: The Not So Forgotten Valve. Manuel J Antunes Cardiothoracic Surgery Coimbra, Portugal

The Tricuspid Valve: The Not So Forgotten Valve. Manuel J Antunes Cardiothoracic Surgery Coimbra, Portugal The Tricuspid Valve: The Not So Forgotten Valve Manuel J Antunes Cardiothoracic Surgery Coimbra, Portugal No Conflicts of Interest to declare with regards to this subject 2 INCIDENCE OF TRICUSPID REGURGITATION

More information

Risk Analysis of the Long-Term Outcomes of the Surgical Closure of Secundum Atrial Septal Defects

Risk Analysis of the Long-Term Outcomes of the Surgical Closure of Secundum Atrial Septal Defects Korean J Thorac Cardiovasc Surg 2017;50:78-85 ISSN: 2233-601X (Print) ISSN: 2093-6516 (Online) CLINICAL RESEARCH https://doi.org/10.5090/kjtcs.2017.50.2.78 Risk Analysis of the Long-Term Outcomes of the

More information

University of Florida Department of Surgery. CardioThoracic Surgery VA Learning Objectives

University of Florida Department of Surgery. CardioThoracic Surgery VA Learning Objectives University of Florida Department of Surgery CardioThoracic Surgery VA Learning Objectives This service performs coronary revascularization, valve replacement and lung cancer resections. There are 2 faculty

More information

Left Ventricular Wall Resection for Aneurysm and Akinesia due to Coronary Artery Disease: Fifty Consecutive Patients

Left Ventricular Wall Resection for Aneurysm and Akinesia due to Coronary Artery Disease: Fifty Consecutive Patients Left Ventricular Wall Resection for Aneurysm and Akinesia due to Coronary Artery Disease: Fifty Consecutive Patients Armand A. Lefemine, M.D., Rajagopalan Govindarajan, M.D., K. Ramaswamy, M.D., Harrison

More information

Extreme pulmonary hypertension caused by mitral valve disease

Extreme pulmonary hypertension caused by mitral valve disease British Heart Journal, I975, 37, 74-78. Extreme pulmonary hypertension caused by mitral valve disease Natural history and results of surgery C. Ward and B. W. Hancock From the Cardio-Thoracic Unit, Northern

More information

The CarboMedics bileaflet prosthetic heart was introduced

The CarboMedics bileaflet prosthetic heart was introduced The CarboMedics Valve: Experience With 1,049 Implants José M. Bernal, MD, José M. Rabasa, MD, Francisco Gutierrez-Garcia, MD, Carlos Morales, MD, J. Francisco Nistal, MD, and José M. Revuelta, MD Department

More information

T sors in the following aspects: the porcine aortic valve

T sors in the following aspects: the porcine aortic valve Clinical and Hemodynamic Assessment of the Hancock I1 Bioprosthesis Tirone E. David, MD, Susan Armstrong, MSc, and Zhao Sun, MA Division of Cardiovascular Surgery, The Toronto Hospital and University of

More information

and Coronary Artery Surgery George M. Callard, M.D., John B. Flege, Jr., M.D., and Joseph C. Todd, M.D.

and Coronary Artery Surgery George M. Callard, M.D., John B. Flege, Jr., M.D., and Joseph C. Todd, M.D. Combined Valvular and Coronary Artery Surgery George M. Callard, M.D., John B. Flege, Jr., M.D., and Joseph C. Todd, M.D. ABSTRACT Between July, 97, and March, 975,45 patients underwent combined valvular

More information

Pulmonary Valve Replacement

Pulmonary Valve Replacement Pulmonary Valve Replacement with Fascia Lata J. C. R. Lincoln, F.R.C.S., M. Geens, M.D., M. Schottenfeld, M.D., and D. N. Ross, F.R.C.S. ABSTRACT The purpose of this paper is to describe a technique of

More information

Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM

Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM The Patient with Aortic Stenosis and Mitral Regurgitation Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM Aortic Stenosis + Mitral Regurgitation?

More information

Mitral Balloon Valvotomy for Patients With Mitral Stenosis in Atrial Fibrillation Immediate and Long-Term Results

Mitral Balloon Valvotomy for Patients With Mitral Stenosis in Atrial Fibrillation Immediate and Long-Term Results Journal of the American College of Cardiology Vol. 34, No. 4, 1999 1999 by the American College of Cardiology ISSN 0735-1097/99/$20.00 Published by Elsevier Science Inc. PII S0735-1097(99)00310-1 Mitral

More information

Reconstruction of the intervalvular fibrous body during aortic and

Reconstruction of the intervalvular fibrous body during aortic and Aortic and mitral valve replacement with reconstruction of the intervalvular fibrous body: An analysis of clinical outcomes Nilto C. De Oliveira, MD Tirone E. David, MD Susan Armstrong, MSc Joan Ivanov,

More information

Conversion of Atriopulmonary to Cavopulmonary Anastomosis in Management of Late Arrhythmias and Atrial Thrombosis

Conversion of Atriopulmonary to Cavopulmonary Anastomosis in Management of Late Arrhythmias and Atrial Thrombosis Conversion of Atriopulmonary to Cavopulmonary Anastomosis in Management of Late Arrhythmias and Atrial Thrombosis Jane M. Kao, MD, Juan c. Alejos, MD, Peter W. Grant, MD, Roberta G. Williams, MD, Kevin

More information

Aortic valve repair is an accepted option for aortic valve

Aortic valve repair is an accepted option for aortic valve Complex Aortic Valve Disease in Children Christopher W. Baird, MD,* and Pedro J. del Nido, MD Aortic valve repair is an accepted option for aortic valve pathologic conditions in children and young adults.

More information

Management of Tricuspid Regurgitation

Management of Tricuspid Regurgitation Management of Tricuspid Regurgitation Antonis A. Pitsis, FETCS, FESC Thessaloniki Heart Institute, St. Luke s Hospital, Thessaloniki, GREECE HEART FAILURE 2012 BELGRADE SERBIA Does Tricuspid Regurgitation

More information

Atrioventricular valve repair: The limits of operability

Atrioventricular valve repair: The limits of operability Atrioventricular valve repair: The limits of operability Francis Fynn-Thompson, MD Co-Director, Center for Airway Disorders Surgical Director, Pediatric Mechanical Support Program Surgical Director, Heart

More information

Long term outcomes of posterior leaflet folding valvuloplasty for mitral valve regurgitation

Long term outcomes of posterior leaflet folding valvuloplasty for mitral valve regurgitation Featured Article Long term outcomes of posterior leaflet folding valvuloplasty for mitral valve regurgitation Igor Gosev 1, Maroun Yammine 1, Marzia Leacche 1, Siobhan McGurk 1, Vladimir Ivkovic 1, Michael

More information

Journal of the American College of Cardiology Vol. 44, No. 9, by the American College of Cardiology Foundation ISSN /04/$30.

Journal of the American College of Cardiology Vol. 44, No. 9, by the American College of Cardiology Foundation ISSN /04/$30. Journal of the American College of Cardiology Vol. 44, 9, 2004 2004 by the American College of Cardiology Foundation ISSN 0735-1097/04/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2004.04.062 Relation

More information

15-Year Comparison of Supra-Annular Porcine and PERIMOUNT Aortic Bioprostheses

15-Year Comparison of Supra-Annular Porcine and PERIMOUNT Aortic Bioprostheses ORIGINAL CONTRIBUTION 15-Year Comparison of Supra-Annular Porcine and PERIMOUNT Aortic Bioprostheses WR Eric Jamieson, MD, Eva Germann, MSc, Michel R Aupart, MD 1, Paul H Neville, MD 1, Michel A Marchand,

More information

Ostium primum defects with cleft mitral valve

Ostium primum defects with cleft mitral valve Thorax (1965), 20, 405. VIKING OLOV BJORK From the Department of Thoracic Surgery, University Hospital, Uppsala, Sweden Ostium primum defects are common; by 1955, 37 operated cases had been reported by

More information

Mitral Valve Disease, When to Intervene

Mitral Valve Disease, When to Intervene Mitral Valve Disease, When to Intervene Swedish Heart and Vascular Institute Ming Zhang MD PhD Interventional Cardiology Structure Heart Disease Conflict of Interest None Current ACC/AHA guideline Stages

More information

Incidence of prosthesis-patient mismatch in patients receiving mitral Biocor porcine prosthetic valves

Incidence of prosthesis-patient mismatch in patients receiving mitral Biocor porcine prosthetic valves INTERVENTION/VALVULAR HEART DISEASE ORIGINAL ARTICLE Cardiology Journal 2016, Vol. 23, No. 2, 178 183 DOI: 10.5603/CJ.a2016.0011 Copyright 2016 Via Medica ISSN 1897 5593 Incidence of prosthesis-patient

More information

Surgical Treatment for Valvular Heart Disease

Surgical Treatment for Valvular Heart Disease Chapter 34 Surgical Treatment for Valvular Heart Disease Peter J. K. Starek Competency of the atrioventricular valves allows blood to enter the ventricles, where pressure is generated. When adequate systolic

More information

The clinical experience reported in recent Western series has provided

The clinical experience reported in recent Western series has provided Surgery for Acquired Cardiovascular Disease Yu et al Long-term evaluation of Carpentier-Edwards porcine bioprosthesis for rheumatic heart disease Hsi-Yu Yu, MD a Yi-Lwun Ho, MD b Shu-Hsun Chu, MD c Yih-Sharng

More information

Long-term results of a strategy of aortic valve repair in the paediatric population: Should we avoid cusp extension?

Long-term results of a strategy of aortic valve repair in the paediatric population: Should we avoid cusp extension? Long-term results of a strategy of aortic valve repair in the paediatric population: Should we avoid cusp extension? Y d Udekem, J Siddiqui, C Seaman, I Konstantinov, J Galati, M Cheung, C Brizard Royal

More information

I challenging management problems in cardiac surgery. Mitral Valve Repair for Ischemic Mitral Insufficiency

I challenging management problems in cardiac surgery. Mitral Valve Repair for Ischemic Mitral Insufficiency Mitral Valve Repair for Ischemic Mitral Insufficiency William G. Hendren, MD, James J. Nemec, MD, Bruce W. Lytle, MD, Floyd D. Loop, MD, Paul C. Taylor, MD, Robert W. Stewart, MD, and Delos M. Cosgrove

More information

Atrial fibrillation (AF) is associated with increased morbidity

Atrial fibrillation (AF) is associated with increased morbidity Ablation of Atrial Fibrillation with Concomitant Surgery Edward G. Soltesz, MD, MPH, and A. Marc Gillinov, MD Atrial fibrillation (AF) is associated with increased morbidity and mortality in coronary artery

More information

The clinical problem of atrioventricular valve regurgitation

The clinical problem of atrioventricular valve regurgitation Mitral Regurgitation in Congenital Heart Defects: Surgical Techniques for Reconstruction Richard G. Ohye Mitral valve regurgitation (MR) is an important source of morbidity and mortality worldwide. While

More information

Valvular Heart Disease

Valvular Heart Disease Valvular Heart Disease MITRAL STENOSIS Pathophysiology rheumatic fever. calcific degeneration, malignant carcinoid disease, congenital mitral stenosis. SLE. The increased pressure gradient across the mitral

More information

PROGRESS IN CARDIOVASCULAR SURGERY. Congenital Mitral Stenosis and Mitral Insufficiency

PROGRESS IN CARDIOVASCULAR SURGERY. Congenital Mitral Stenosis and Mitral Insufficiency PROGRESS IN CARDIOVASCULAR SURGERY Congenital Mitral Stenosis and Mitral Insufficiency GEORGE W. B. STARKEY, M.D.* Boston, Massachusetts CONGENITAL MITRAL STENOSIS AND mitral insufficiency are rare, particularly

More information

Kinsing Ko, Thom de Kroon, Najim Kaoui, Bart van Putte, Nabil Saouti. St. Antonius Hospital, Nieuwegein, The Netherlands

Kinsing Ko, Thom de Kroon, Najim Kaoui, Bart van Putte, Nabil Saouti. St. Antonius Hospital, Nieuwegein, The Netherlands Minimal Invasive Mitral Valve Surgery After Previous Sternotomy Without Aortic Clamping: Short- and Long Term Results of a Single Surgeon Single Institution Kinsing Ko, Thom de Kroon, Najim Kaoui, Bart

More information

Degenerative Mitral Regurgitation: Etiology and Natural History of Disease and Triggers for Intervention

Degenerative Mitral Regurgitation: Etiology and Natural History of Disease and Triggers for Intervention Degenerative Mitral Regurgitation: Etiology and Natural History of Disease and Triggers for Intervention John N. Hamaty D.O. FACC, FACOI November 17 th 2017 I have no financial disclosures Primary Mitral

More information

Mitral Valve Disease. Prof. Sirchak Yelizaveta Stepanovna

Mitral Valve Disease. Prof. Sirchak Yelizaveta Stepanovna Mitral Valve Disease Prof. Sirchak Yelizaveta Stepanovna Fall 2008 Mitral Valve Stenosis Lecture Outline Mitral Stenosis Mitral Regurgitation Etiology Pathophysiology Clinical features Diagnostic testing

More information

Tricuspid and Pulmonic Valve Disease

Tricuspid and Pulmonic Valve Disease Chapter 31 Tricuspid and Pulmonic Valve Disease David A. Tate Acquired disease of the right-sided cardiac valves is much less common than disease of the leftsided counterparts, possibly because of the

More information

Index. interventional.theclinics.com. Note: Page numbers of article titles are in boldface type.

Index. interventional.theclinics.com. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Ablation, of mitral leaflets, 80 Accucinch Annuloplasty system, for mitral regurgitation, 79, 94 95 Accutrak delivery system, for CoreValve

More information

Clinical material and methods. Copyright by ICR Publishers 2007

Clinical material and methods. Copyright by ICR Publishers 2007 16847_JHVD_Biancari_3197_(116-121)_r1:Layout 1 21/3/07 17:07 Page 116 Predicting Immediate and Late Outcome after Surgery for Mitral Valve Regurgitation with EuroSCORE Jouni Heikkinen, Fausto Biancari,

More information

Rheumatic fever and rheumatic heart disease still remain a. The Rheumatic Mitral Valve and Repair Techniques in Children. Afksendiyos Kalangos

Rheumatic fever and rheumatic heart disease still remain a. The Rheumatic Mitral Valve and Repair Techniques in Children. Afksendiyos Kalangos The Rheumatic Mitral Valve and Repair Techniques in Children Afksendiyos Kalangos The mitral valve is the most commonly affected valve in acute and chronic rheumatic heart disease in the first and second

More information

The increase in the lifespan of the western population

The increase in the lifespan of the western population Outcome After Aortic Valve Replacement in Octogenarians Bruno Chiappini, MD, Nicola Camurri, MD, Antonio Loforte, MD, Luca Di Marco, MD, Roberto Di Bartolomeo, MD, and Giuseppe Marinelli, MD Department

More information

Chapter 24: Diagnostic workup and evaluation: eligibility, risk assessment, FDA guidelines Ashwin Nathan, MD, Saif Anwaruddin, MD, FACC Penn Medicine

Chapter 24: Diagnostic workup and evaluation: eligibility, risk assessment, FDA guidelines Ashwin Nathan, MD, Saif Anwaruddin, MD, FACC Penn Medicine Chapter 24: Diagnostic workup and evaluation: eligibility, risk assessment, FDA guidelines Ashwin Nathan, MD, Saif Anwaruddin, MD, FACC Penn Medicine Mitral regurgitation, regurgitant flow between the

More information

HISTORY. Question: How do you interpret the patient s history? CHIEF COMPLAINT: Dyspnea of two days duration. PRESENT ILLNESS: 45-year-old man.

HISTORY. Question: How do you interpret the patient s history? CHIEF COMPLAINT: Dyspnea of two days duration. PRESENT ILLNESS: 45-year-old man. HISTORY 45-year-old man. CHIEF COMPLAINT: Dyspnea of two days duration. PRESENT ILLNESS: His dyspnea began suddenly and has been associated with orthopnea, but no chest pain. For two months he has felt

More information

14 Valvular Stenosis

14 Valvular Stenosis 14 Valvular Stenosis 14-1. Valvular Stenosis unicuspid valve FIGUE 14-1. This photograph shows severe valvular stenosis as it occurs in a newborn. There is a unicuspid, horseshoe-shaped leaflet with a

More information

Adult Echocardiography Examination Content Outline

Adult Echocardiography Examination Content Outline Adult Echocardiography Examination Content Outline (Outline Summary) # Domain Subdomain Percentage 1 2 3 4 5 Anatomy and Physiology Pathology Clinical Care and Safety Measurement Techniques, Maneuvers,

More information

What is the Role of Surgical Repair in 2012

What is the Role of Surgical Repair in 2012 What is the Role of Surgical Repair in 2012 The Long-Term Results of Surgery Raphael Rosenhek Department of Cardiology Medical University of Vienna European Society of Cardiology 2012 Munich, August 27th

More information

Severe left ventricular dysfunction and valvular heart disease: should we operate?

Severe left ventricular dysfunction and valvular heart disease: should we operate? Severe left ventricular dysfunction and valvular heart disease: should we operate? Laurie SOULAT DUFOUR Hôpital Saint Antoine Service de cardiologie Pr A. COHEN JESFC 16 janvier 2016 Disclosure : No conflict

More information

Aortic stenosis (AS) is common with the aging population.

Aortic stenosis (AS) is common with the aging population. New Insights Into the Progression of Aortic Stenosis Implications for Secondary Prevention Sanjeev Palta, MD; Anita M. Pai, MD; Kanwaljit S. Gill, MD; Ramdas G. Pai, MD Background The risk factors affecting

More information

Balloon Valvuloplasty for Recurrent Aortic Stenosis After Surgical Valvotomy in Childhood: Immediate and Follow-Up Studies

Balloon Valvuloplasty for Recurrent Aortic Stenosis After Surgical Valvotomy in Childhood: Immediate and Follow-Up Studies 1106 JACC Vol. 13, No. 5 April 1989: 1106-10 Balloon Valvuloplasty for Recurrent Aortic Stenosis After Surgical Valvotomy in Childhood: Immediate and Follow-Up Studies JON N. MELIONES, MD, ROBERT H. BEEKMAN,

More information

Disclosures. ESC Munich 2012 Bernard Iung, MD Consultancy: Abbott Boehringer Ingelheim Bayer Servier Valtech

Disclosures. ESC Munich 2012 Bernard Iung, MD Consultancy: Abbott Boehringer Ingelheim Bayer Servier Valtech Disclosures ESC Munich 2012 Bernard Iung, MD Consultancy: Abbott Boehringer Ingelheim Bayer Servier Valtech Speaker s fee Edwards Lifesciences Sanofi-Aventis Decision Making in Patients with Multivalvular

More information

It is controversial whether to perform aortic valve replacement

It is controversial whether to perform aortic valve replacement Management of Patients With Mild Aortic Stenosis Undergoing Coronary Artery Bypass Grafting James W. Tam, MD, Roy G. Masters, MD, Ian G. Burwash, MD, Alain D. Mayhew, BS, and Kwan-Leung Chan, MD University

More information